SCHEMBL31240732

SCHEMBL31240732

Nc1n[nH]c2ccc(-c3ccnc(NCc4ccc(C(F)(F)F)cc4)c3)cc12

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 6/20 0.51
▸ CDC7 O00311 2/20 0.48
▸ MAPK1 P28482 2/20 0.44
▸ DYRK1A Q13627 3/20 0.43
▸ CCNE1 P24864 1/20 0.43
▸ CDK2 P24941 1/20 0.43
▸ DBF4 Q9UBU7 1/20 0.43
▸ MAP2K4 P45985 2/20 0.41
▸ MAPKAPK2 P49137 1/20 0.41
▸ MAPKAPK3 Q16644 1/20 0.41
▸ MAPK6 Q16659 1/20 0.41
▸ MAPK14 Q16539 2/20 0.41
▸ EPHX2 P34913 1/20 0.41
▸ APP P05067 1/20 0.41
▸ EGFR P00533 1/20 0.40
▸ ACHE P22303 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240408 0.89 MAPK14 (0.49) JAK2CDC7DYRK1ACCNE1CDK2
SCHEMBL31240273 0.87 JAK2 (0.47) JAK2CDC7DYRK1ACCNE1CDK2
SCHEMBL31240411 0.85 CDC7 (0.58) JAK2CDC7MAPK1DYRK1ACCNE1
SCHEMBL31240404 0.84 MAPK14 (0.52) JAK2CDC7MAPK1DYRK1ACDK2
SCHEMBL31240395 0.83 LRRK2 (0.54) JAK2CDC7MAPK1DYRK1ACCNE1
SCHEMBL31240462 0.81 JAK2 (0.54) JAK2CDC7DYRK1ACCNE1CDK2
SCHEMBL31240440 0.80 JAK2 (0.45) JAK2CDC7DYRK1ACDK2MAPK14
SCHEMBL31240476 0.80 JAK2 (0.50) JAK2CDC7DYRK1ACCNE1CDK2
SCHEMBL12907182 0.79 JAK2 (0.69) JAK2CDC7MAPK1DYRK1ACDK2
SCHEMBL26686356 0.79 JAK2 (0.57) JAK2CDC7DYRK1ACDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback